AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | +20.8% | 5,560 | +23.9% | 0.00% | 0.0% |
| Q2 2023 | $322 | +49.1% | 4,487 | +60.0% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 2,805 | -51.0% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | +3.5% | 5,722 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $229,000 | -67.8% | 6,049 | -42.6% | 0.00% | -66.7% |
| Q2 2021 | $711,000 | +25.2% | 10,540 | +5.0% | 0.00% | 0.0% |
| Q1 2021 | $568,000 | -30.0% | 10,040 | +0.9% | 0.00% | -25.0% |
| Q4 2020 | $811,000 | +18.0% | 9,955 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $687,000 | -22.5% | 9,643 | -10.5% | 0.00% | -33.3% |
| Q2 2020 | $886,000 | +80.1% | 10,772 | +28.9% | 0.01% | +50.0% |
| Q1 2020 | $492,000 | -78.7% | 8,356 | -62.6% | 0.00% | -73.3% |
| Q4 2019 | $2,311,000 | +301.2% | 22,360 | -21.5% | 0.02% | +275.0% |
| Q3 2019 | $576,000 | -18.8% | 28,475 | +3.5% | 0.00% | -20.0% |
| Q2 2019 | $709,000 | +183.6% | 27,525 | +56.6% | 0.01% | +150.0% |
| Q1 2019 | $250,000 | – | 17,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |